Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia
NCT05891847 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2025-06-10
Summary
The purpose of this study is to evaluate the effectiveness, safety of selumetinib and patient's parameters of symptomatic inoperable PN NF1 in real clinical practice in Russia
Conditions
- Neurofibroma
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 3 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-21
- Primary Completion
- 2026-03-20
- Completion
- 2026-03-20
Countries
- Russia
Study Locations
More Related Trials
-
A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants
NCT03649165 ·Status: COMPLETED ·Phase: PHASE1
-
N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan
NCT02030964 ·Status: COMPLETED ·Phase: PHASE1
-
Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).
NCT06159166 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease
NCT04026165 ·Status: COMPLETED ·Phase: PHASE2
-
Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients
NCT00489372 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders
NCT02425904 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
NCT00099047 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
NCT05184816 ·Status: RECRUITING ·Phase: PHASE1
-
Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodotin
NCT04549363 ·Status: TERMINATED ·Phase: PHASE3
-
Study of the Tolerability and Pharmacokinetics of Oral Doses of SAR442168 With a Food Effect Investigation in Healthy Adult Participants
NCT06106074 ·Status: COMPLETED ·Phase: PHASE1
-
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
NCT04079179 ·Status: RECRUITING ·Phase: PHASE2
-
Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
NCT01793051 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions
NCT06132243 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers
NCT06987708 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Celecoxib in Treating Patients With Precancerous Lesions of the Mouth
NCT00014404 ·Status: COMPLETED ·Phase: PHASE2
-
Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas
NCT04750928 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
NCT00571701 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Selenomethionine and Myo-inositol(SOLOWAYS_TM) in Patients With Autoimmune Thyroiditis Carrying the DIO2 Thr92Ala Polymorphism
NCT06867913 ·Status: COMPLETED ·Phase: NA
-
Celecoxib in Preventing Lung Cancer in Former Heavy Smokers
NCT00055978 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)
NCT00198081 ·Status: TERMINATED ·Phase: PHASE2
-
Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
NCT00052611 ·Status: COMPLETED ·Phase: PHASE2
-
Quantitative MRI for Myelofibrosis
NCT01973881 ·Status: RECRUITING
-
Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses
NCT00027976 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).
NCT06581848 ·Status: ACTIVE_NOT_RECRUITING
-
Prevention of Treatment Induced Neuropathy in Multiple Myeloma
NCT01283997 ·Status: COMPLETED ·Phase: PHASE2